Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Amir Sobh-Rakhshankhah"'
Autor:
Ali Vasheghani Farahani, Haleh Ashraf, Vina Goudarzi, Mohammad Ali Boroumand, Samira Jafari, Amir Sobh-Rakhshankhah, Farzad Masoudkabir, Danesh Soltani
Publikováno v:
Cytokine. 113:216-220
Several studies have demonstrated the relationship between visfatin and increased risk of diseases caused by inflammation, however, the relationship between visfatin and coronary artery ectasia (CAE) is still unknown. The aim of our study is to inves
Autor:
Haleh Ashraf, Amir Sobh-Rakhshankhah, Zahra Kolahchi, Ali Vasheghani-Farahani, Danesh Soltani, Farzad Masoudkabir, Samira Jafari, Mohammad Ali Boroumand
Publikováno v:
Heart international. 14(1)
Several studies have reported an association between elevated liver enzymes and increased risks for developing inflammatory diseases. The aim of our study was to examine how serum liver transaminases, as inexpensive and routinely measured markers, an
Autor:
Amir Sobh-Rakhshankhah, Reza Rahmani, Naeimeh Hashemi, Marco Guazzi, Sepideh Niyazi, Hamid-Reza Khoddami-Vishteh, Reza Mazaheri
Publikováno v:
Journal of cardiopulmonary rehabilitation and prevention. 40(1)
PURPOSE Because of uncertainty in the pathophysiological process, the treatment of cardiac syndrome X (CSX) is still under study. Addressing the effects of cardiac rehabilitation (CR) can help promote the prescription of this modality as an adjuvant
Autor:
Sepideh Saroukhani, Mohammad Alidoosti, Masoumeh Lotfi-Tokaldany, Amir Sobh-Rakhshankhah, Arash Jalali
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 17(5)
Previous studies reported conflicting results regarding the impact of incomplete revascularization on the outcome of percutaneous coronary intervention (PCI). We evaluated the association between residual SYNTAX score (RSS) as a quantitative measure
Autor:
Yahya Dadjou, Bahram Pishgoo, Hamid Reza Taghipour, Amirhossein Sahebkar, Amir Sobh Rakhshankhah, Yunes Panahi
Publikováno v:
Clinical Laboratory. 59
Aortic stenosis (AS) is the most common type of valvular cardiac disorders. AS has many risk factors in common with atherosclerosis. Hypercholesterolemia is an important pathomechanism for AS. However, the impact of statin drugs on slowing AS progres
Publikováno v:
Catheterization & Cardiovascular Interventions; May2014 Supplement, Vol. 83, pS1-S247, 247p
Autor:
Soltani D; Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran., Jafari S; Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran., Ashraf H; Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran., Sobh-Rakhshankhah A; Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran., Kolahchi Z; Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran., Masoudkabir F; Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Cardiology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran., Boroumand MA; Department of Pathology and Laboratory Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran., Vasheghani-Farahani A; Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Publikováno v:
Heart international [Heart Int] 2020 Jul 31; Vol. 14 (1), pp. 43-48. Date of Electronic Publication: 2020 Jul 31 (Print Publication: 2020).